Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01045668
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01045668
-
- Other papers using this trial's data
- Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01045668. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2013-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
- Acronym
- VISTA
- Condition
- Ventricular Tachycardia
- Intervention (Procedure)
- Radiofrequency Catheter Ablation (RFCA)
- Intervention (Procedure)
- Radiofrequency Catheter Ablation (RFCA)
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Collaborator
- University of Kansas
- Collaborator
- California Pacific Medical Center
- Collaborator
- Stanford University
- Collaborator
- Case Western Reserve University
- Collaborator
- Southlake Health
- Collaborator
- Catholic University, Italy
- Collaborator
- Ospedale dell'Angelo, Venezia-Mestre
- Collaborator
- RCCS Monzino Hospital, Milan, Italy
- Collaborator
- University of Rome Tor Vergata
Record details
- Record id
cardio:ct-nct01045668- Content hash
ec7934dfd9b341adbd5a31a5deb2520c13f62b269e1936a387fe10c75ed57e40